Hepatitis C

Case Report: Nephrotic Syndrome and Chronic HCV in a 72-Year-Old Woman

Case Report: Nephrotic Syndrome and Chronic HCV in a 72-Year-Old Woman

By

A 72-year-old Japanese woman with a 40-year history of lupus nephritis presented with leg edema that had lasted for several weeks.

Screening insufficient for newborns exposed to hepatitis C virus

In this retrospective study, only a fraction of infants receiving well-child care at the study institution were screened for hepatitis C, despite being born to mothers with a known history of hepatitis C virus infection.

Hepatitis C Screening Increasing Among Baby Boomers

Hepatitis C Screening Increasing Among Baby Boomers

Screening prevalence 11.5 to 12.8%; similar rate for cohort born from 1966 to 1985

Effectiveness of Shortened Treatment Regimen for Hepatitis C Assessed

Effectiveness of Shortened Treatment Regimen for Hepatitis C Assessed

In this large, real-world cohort of patients with chronic hepatitis C virus infection, equivalent sustained virologic response rates were found with both 8-week and 12-week treatment.

Direct-Acting Antivirals Improve Liver Transplant Survival

Direct-Acting Antivirals Improve Liver Transplant Survival

Direct-acting antivirals improved the survival of patients undergoing liver transplantation for HCV-related liver disease.

HCV treatment with direct antiviral agents improves carotid atherosclerosis

HCV treatment with direct antiviral agents improves carotid atherosclerosis

By

Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis and compensated cirrhosis.

Prophylaxis may protect kidney recipients from HCV

Prophylaxis may protect kidney recipients from HCV

Prophylaxis safely, effectively prevents HCV transmittance in noninfected patients receiving kidney transplants from HCV-positive donors.

Drug combination effective for hepatitis C

Drug combination effective for hepatitis C

By

Elbasvir and grazoprevir, taken in combination for 12 weeks, successfully treated virologic response in patient with hepatitis C genotype 1b.

Once daily glecaprevir-pibrentasvir treats HCV genotype 1,3

Once daily glecaprevir-pibrentasvir treats HCV genotype 1,3

Once daily glecaprevir-pibrentasvir for 8 or 12 weeks successfully treated HCV genotype 1 and 3.

HCV treatment hinders liver fibrosis progression

HCV treatment hinders liver fibrosis progression

By

Patients with chronic HCV with a sustained virologic response were more likely to have a reduced progression of liver fibrosis.

Hepatitis increases mortality rates in HIV patients

Hepatitis increases mortality rates in HIV patients

By

Hepatitis B and hepatitis C may increase mortality risks in HIV patients.

Nurse practitioner treatment of hepatitis C in primary care

Nurse practitioner treatment of hepatitis C in primary care

By

Hepatitis C treatment improves outcomes and experiences for patient and provider.

Updated hepatitis C recommendations include kidney transplant, pregnant patients

Updated hepatitis C recommendations include kidney transplant, pregnant patients

By

The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America have added updates to the hepatitis C guidelines to include kidney transplant, pregnant, and pediatric patients.

Hepatocellular carcinoma risk unclear after hepatitis C treatment

Hepatocellular carcinoma risk unclear after hepatitis C treatment

The results show no evidence to support a hypothesis of differential impact of interferon and direct-acting antiviral-based cure on risk for HCC occurrence and recurrence.

Primary care providers and nurse practitioners can expand HCV treatment access

Primary care providers and nurse practitioners can expand HCV treatment access

Primary care providers and nurse practitioners achieve the same sustained virologic response rates as specialists.

Electronic health record-based prompt increases hepatitis C screenings in baby boomers

Electronic health record-based prompt increases hepatitis C screenings in baby boomers

The prompt increased hepatitis C screening rates among baby boomers in primary care by 5-fold.

Blood-borne viruses more common in patients with severe mental illness

Blood-borne viruses more common in patients with severe mental illness

By

HIV, hepatitis B, and hepatitis C infections are more common among individuals with severe mental illness.

WHO updates Essential Medicines List, recommendations for antibiotics

WHO updates Essential Medicines List, recommendations for antibiotics

By

The update includes 30 new medicines for adults and 25 for children and groups antibiotics into 3 distinct categories.

High HCV cure rates in patients with HIV coinfection at urban clinic

High HCV cure rates in patients with HIV coinfection at urban clinic

Hepatitis C treatment in HIV coinfection cases is effective with standardized nurse and pharmacist support for patients in an urban clinic.

HCV transmission knowledge varies among opioid-dependent pregnant patients

HCV transmission knowledge varies among opioid-dependent pregnant patients

By

Most opioid-dependent pregnant patients understand that intravenous drug use is a major transmission modality of HCV.

Statins may lower risk of cirrhosis decompensation in HBV and HCV

Statins may lower risk of cirrhosis decompensation in HBV and HCV

Statin use decreased rates of decompensation in patients with liver cirrhosis due to HBV and HCV infections and in patients with alcohol-induced cirrhosis.

AGA Institute releases practice update for managing patients cured of HCV infection

AGA Institute releases practice update for managing patients cured of HCV infection

Patients with chronic HCV infection who have achieved a sustained virologic response with treatment may still be at risk for complications such as hepatocellular carcinoma.

NASEM report aims to eliminate hepatitis B and C by 2030

NASEM report aims to eliminate hepatitis B and C by 2030

By

Aggressive testing, diagnosis, treatment, and prevention methods, such as needle exchange for those who inject drugs, are some of the options that the NASEM explored to target hepatitis elimination.

FDA approves first direct-acting antivirals for pediatric HCV patients

FDA approves first direct-acting antivirals for pediatric HCV patients

By

Harvoni and Sovaldi have been approved for pediatric patients with HCV genotypes.

Oral, direct-acting antivirals effective for hepatitis C virus infection

Oral, direct-acting antivirals effective for hepatitis C virus infection

By

Regimens for the treatment of hepatitis C that included ribavirin had more mild or moderate adverse events than those without.

Pharmacists can help optimize care in patients with hepatitis C virus

Pharmacists can help optimize care in patients with hepatitis C virus

By

Drug-drug interactions are common in patients taking hepatitis C virus medications, and consulting with a pharmacist can be beneficial.

Hepatitis C infection linked to nonhepatic cancers among elderly patients

Hepatitis C infection linked to nonhepatic cancers among elderly patients

HCV infection is associated with cancers such as bile duct and pancreatic cancers and diffuse large B-cell lymphoma.

HCV patients with diabetes may have increased risk of hepatocellular carcinoma

HCV patients with diabetes may have increased risk of hepatocellular carcinoma

Diabetes could increase the risk of developing hepatocellular carcinoma in patients with hepatitis C.

VA offers hepatitis, HIV screening to veterans who received improper dental care

VA offers hepatitis, HIV screening to veterans who received improper dental care

By

A VA center in Wisconsin is advising veterans to be screened for hepatitis and HIV after receiving care from a dentist who did not follow VA procedures.

Ledipasvir-sofosbuvir treatment safe for kidney recipients with hepatitis C

Ledipasvir-sofosbuvir treatment safe for kidney recipients with hepatitis C

Treatment for 12 or 24 weeks is safe and efficacious for kidney transplant recipients with hepatitis C virus.

Sign Up for Free e-newsletters